Pear Therapeutics Announces First Participant Enrolled in National Institutes of Health Clinical Trial Investigating Combinations of Pharmacological and Behavioral Interventions to Treat Opioid Use Disorder
Starkey Sponsors AG Bell Symposium
Nexben Adds to Leadership Team; Hires Chief Technology Officer to Support Continued Growth
Miracle-Ear Foundation Wins Distinguished Franchise Update Media 2021 Innovation Award